{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:49:46Z","timestamp":1787863786290,"version":"build-2784847793"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/25\/2018-NAN\/BMS"],"award-info":[{"award-number":["45\/25\/2018-NAN\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11033-020-06054-6","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T12:06:04Z","timestamp":1611576364000},"page":"1773-1786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Mechanism of tumour microenvironment in the progression and development of oral cancer"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5533-8135","authenticated-orcid":false,"given":"Mohd","family":"Mughees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1434-3982","authenticated-orcid":false,"given":"Anindita","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4241-5453","authenticated-orcid":false,"given":"Sapna","family":"Khowal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-8233","authenticated-orcid":false,"given":"Saima","family":"Wajid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"issue":"46","key":"6054_CR1","doi-asserted-by":"crossref","first-page":"81617","DOI":"10.18632\/oncotarget.20312","volume":"8","author":"R Ai","year":"2017","unstructured":"Ai R, Tao Y, Hao Y, Jiang L, Dan H, Ji N, Zeng X, Zhou Y, Chen Q (2017) Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy. Oncotarget 8(46):81617","journal-title":"Oncotarget"},{"key":"6054_CR2","unstructured":"American Cancer Society (2020) Cancer facts and figures 2020. https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2020.html"},{"issue":"12","key":"6054_CR3","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/jamaoto.2014.1539","volume":"140","author":"M Amit","year":"2014","unstructured":"Amit M, Yen TC, Liao CT, Chaturvedi P, Agarwal JP, Kowalski LP, Kohler HF, Ebrahimi A, Clark JR, Cernea CR, Brandao JS, Kreppel M, Z\u00f6ller JE, Leider-Trejo L, Bachar G, Shpitzer T, Bolzoni AV, Patel RP, Jonnalagadda S, Robbins TK, Shah JP, Patel SG, Gil Z (2014) The origin of regional failure in oral cavity squamous cell carcinoma with pathologically negative neck metastases. JAMA Otolaryngol Head Neck Surg 140(12):1130\u20131137. https:\/\/doi.org\/10.1001\/jamaoto.2014.1539","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"8","key":"6054_CR4","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/ijc.29945","volume":"138","author":"L Andzinski","year":"2016","unstructured":"Andzinski L, Kasnitz N, Stahnke S, Wu CF, Gereke M, von K\u00f6ckritz-Blickwede M, Schilling B, Brandau S, Weiss S, Jablonska J (2016) Type I IFN s induce anti-tumor polarization of tumor associated neutrophils in mice and human. Int J Cancer 138(8):1982\u20131993","journal-title":"Int J Cancer"},{"issue":"3","key":"6054_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4103\/jomfp.JOMFP_325_19","volume":"23","author":"VM Anne Gowda","year":"2019","unstructured":"Anne Gowda VM, Smitha T (2019) The dendritic cell tool for oral cancer treatment. J Oral Maxillofac Pathol 23(3):326\u2013329. https:\/\/doi.org\/10.4103\/jomfp.JOMFP_325_19","journal-title":"J Oral Maxillofac Pathol"},{"key":"6054_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","volume":"5","author":"G Arango Duque","year":"2014","unstructured":"Arango Duque G, Descoteaux A (2014) Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol 5:491. https:\/\/doi.org\/10.3389\/fimmu.2014.00491","journal-title":"Front Immunol"},{"issue":"1","key":"6054_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/medicina56010015","volume":"56","author":"B Arneth","year":"2020","unstructured":"Arneth B (2020) Tumor Microenvironment. Medicina (Kaunas) 56(1):15","journal-title":"Medicina (Kaunas)"},{"key":"6054_CR8","doi-asserted-by":"crossref","unstructured":"Bernal MO, Chepeha D, Prawira A, Vines D, Spreafico A, Bratman S, Siu LL (2019) Abstract CT124: Sitravatinib and nivolumab in oral cavity cancer window of opportunity study (SNOW)","DOI":"10.1158\/1538-7445.SABCS18-CT124"},{"issue":"1","key":"6054_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40425-019-0580-6","volume":"7","author":"KF Bol","year":"2019","unstructured":"Bol KF, Schreibelt G, Rabold K, Wculek SK, Schwarze JK, Dzionek A, Teijeira A, Kandalaft LE, Romero P, Coukos G, Neyns B, Sancho D, Melero I, de Vries IJM (2019) The clinical application of cancer immunotherapy based on naturally circulating dendritic cells. J Immunother Cancer 7(1):109. https:\/\/doi.org\/10.1186\/s40425-019-0580-6","journal-title":"J Immunother Cancer"},{"issue":"11","key":"6054_CR10","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.4049\/jimmunol.1500959","volume":"195","author":"CC Bozkus","year":"2015","unstructured":"Bozkus CC, Elzey BD, Crist SA, Ellies LG, Ratliff TL (2015) Expression of cationic amino acid transporter 2 is required for myeloid-derived suppressor cell\u2013mediated control of T cell immunity. J Immunol 195(11):5237\u20135250","journal-title":"J Immunol"},{"issue":"6","key":"6054_CR11","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clinicians 68(6):394\u2013424","journal-title":"CA: Cancer J Clinicians"},{"issue":"1","key":"6054_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen S-H, Colombo MP, Frey AB, Greten TF, Mandruzzato S, Murray PJ, Ochoa A, Ostrand-Rosenberg S (2016) Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 7(1):1\u201310","journal-title":"Nat Commun"},{"issue":"1","key":"6054_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1487-2","volume":"39","author":"M-X Cao","year":"2020","unstructured":"Cao M-X, Zhang W-L, Yu X-H, Wu J-S, Qiao X-W, Huang M-C, Wang K, Wu J-B, Tang Y-J, Jiang J, Research CC (2020) Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression. J Exp Clin Cancer Res 39(1):1\u201318","journal-title":"J Exp Clin Cancer Res"},{"key":"6054_CR14","doi-asserted-by":"crossref","unstructured":"Carlomagno N, Incollingo P, Tammaro V, Peluso G, Rupealta N, Chiacchio G, Sandoval Sotelo ML, Minieri G, Pisani A, Riccio E (2017) Diagnostic, predictive, prognostic, and therapeutic molecular biomarkers in third millennium: a breakthrough in gastric cancer. Biomed Res Int 2017","DOI":"10.1155\/2017\/7869802"},{"issue":"18","key":"6054_CR15","doi-asserted-by":"crossref","first-page":"16253","DOI":"10.18632\/oncotarget.3608","volume":"6","author":"S-C Chen","year":"2015","unstructured":"Chen S-C, Hu T-H, Huang C-C, Kung M-L, Chu T-H, Yi L-N, Huang S-T, Chan H-H, Chuang J-H, Liu L-F (2015) Hepatoma-derived growth factor\/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis. Oncotarget 6(18):16253","journal-title":"Oncotarget"},{"issue":"10","key":"6054_CR16","first-page":"1489","volume":"11","author":"X Chen","year":"2011","unstructured":"Chen X, Oppenheim J (2011) Resolving the identity myth: key markers of functional CD4+ FoxP3+ regulatory T cells. Sci Rep 11(10):1489\u20131496","journal-title":"Sci Rep"},{"issue":"1","key":"6054_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"X Cheng","year":"2017","unstructured":"Cheng X, Wu H, Jin Z-J, Ma D, Yuen S, Jing X-Q, Shi M-M, Shen B-Y, Peng C-H, Zhao R (2017) Up-regulation of chemokine receptor CCR4 is associated with human hepatocellular carcinoma malignant behavior. Sci Rep 7(1):1\u201314","journal-title":"Sci Rep"},{"key":"6054_CR18","doi-asserted-by":"crossref","unstructured":"Dar AA, Patil RS, Pradhan TN, Chaukar DA, D\u2019Cruz AK, Chiplunkar SV (2020). Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinoma. Cancer Immunol Immunotherapy, 1\u201316","DOI":"10.1007\/s00262-020-02523-w"},{"key":"6054_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mehy.2017.07.017","volume":"108","author":"M de Sousa Lopes","year":"2017","unstructured":"de Sousa Lopes M, Liu Y, Liu KY, da Silveira \u00c9, Poh CF (2017) Tumor-associated immune aggregates in oral cancer: their cellular composition and potential prognostic significance. Med Hypotheses 108:17\u201323. https:\/\/doi.org\/10.1016\/j.mehy.2017.07.017","journal-title":"Med Hypotheses"},{"issue":"8","key":"6054_CR20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220101","volume":"14","author":"M Dolan","year":"2019","unstructured":"Dolan M, Mastri M, Tracz A, Christensen JG, Chatta G, Ebos JM (2019) Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance. PLoS One 14(8):e0220101","journal-title":"PLoS One"},{"issue":"1","key":"6054_CR21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s40425-019-0593-1","volume":"7","author":"S Domingos-Pereira","year":"2019","unstructured":"Domingos-Pereira S, Galliverti G, Hanahan D, Nardelli-Haefliger D (2019) Carboplatin\/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors. J Immunother Cancer 7(1):122","journal-title":"J Immunother Cancer"},{"issue":"3","key":"6054_CR22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"16","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM (2009) Polarization of tumor-associated neutrophil phenotype by TGF-\u03b2:\u201cN1\u201d versus \u201cN2\u201d TAN. Cancer Cell 16(3):183\u2013194","journal-title":"Cancer Cell"},{"key":"6054_CR23","doi-asserted-by":"crossref","unstructured":"Fujita S, Sumi M, Tatsukawa E, Nagano K, Katase N (2020) Expressions of extracellular matrix-remodeling factors in lymph nodes from oral cancer patients. Oral Dis","DOI":"10.1111\/odi.13419"},{"issue":"6","key":"6054_CR24","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.21873\/anticanres.12587","volume":"38","author":"D Ganesh","year":"2018","unstructured":"Ganesh D, Sreenivasan P, \u00d6hman J, Wallstr\u00f6m M, Braz-Silva PH, Giglio D, Kjeller G, Hass\u00e9us B (2018) Potentially malignant oral disorders and cancer transformation. Anticancer Res 38(6):3223\u20133229. https:\/\/doi.org\/10.21873\/anticanres.12587","journal-title":"Anticancer Res"},{"issue":"7","key":"6054_CR25","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","volume":"189","author":"C Germain","year":"2014","unstructured":"Germain C, Gnjatic S, Tamzalit F, Knockaert S, Remark R, Goc J, Lepelley A, Becht E, Katsahian S, Bizouard G, Validire P, Damotte D, Alifano M, Magdeleinat P, Cremer I, Teillaud JL, Fridman WH, Saut\u00e8s-Fridman C, Dieu-Nosjean MC (2014) Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med 189(7):832\u2013844. https:\/\/doi.org\/10.1164\/rccm.201309-1611OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"6054_CR26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/odi.13140","volume":"26","author":"D Graizel","year":"2020","unstructured":"Graizel D, Zlotogorski-Hurvitz A, Tsesis I, Rosen E, Kedem R, Vered M (2020) Oral cancer-associated fibroblasts predict poor survival: systematic review and meta-analysis. Oral Dis 26(4):733\u2013744","journal-title":"Oral Dis"},{"issue":"1","key":"6054_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cell.2005.10.036","volume":"124","author":"M Grunewald","year":"2006","unstructured":"Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S, Chimenti S, Landsman L, Abramovitch R, Keshet E (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124(1):175\u2013189","journal-title":"Cell"},{"key":"6054_CR28","doi-asserted-by":"crossref","first-page":"101174","DOI":"10.1016\/j.redox.2019.101174","volume":"25","author":"SY Gun","year":"2019","unstructured":"Gun SY, Lee SWL, Sieow JL, Wong SC (2019) Targeting immune cells for cancer therapy. Redox Biol 25:101174","journal-title":"Redox Biol"},{"issue":"1","key":"6054_CR29","first-page":"65","volume":"13","author":"S Han","year":"2020","unstructured":"Han S, Yin X, Wang Y, Xu W, Cheng W (2020) Co-expression of HIF-1 and TLR3 is associated with poor prognosis in oral squamous cell carcinoma. Int J Clin Exp Pathol 13(1):65","journal-title":"Int J Clin Exp Pathol"},{"key":"6054_CR30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","volume":"6","author":"E Henke","year":"2020","unstructured":"Henke E, Nandigama R, Erg\u00fcn S (2020) Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front Mol Biosci 6:160","journal-title":"Front Mol Biosci"},{"issue":"11","key":"6054_CR31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejcb.2016.06.002","volume":"95","author":"C-M Horejs","year":"2016","unstructured":"Horejs C-M (2016) Basement membrane fragments in the context of the epithelial-to-mesenchymal transition. Eur J Cell Biol 95(11):427\u2013440","journal-title":"Eur J Cell Biol"},{"issue":"20","key":"6054_CR32","doi-asserted-by":"crossref","first-page":"32783","DOI":"10.18632\/oncotarget.15824","volume":"8","author":"C-H Hsin","year":"2017","unstructured":"Hsin C-H, Chou Y-E, Yang S-F, Su S-C, Chuang Y-T, Lin S-H, Lin C-W (2017) MMP-11 promoted the oral cancer migration and Fak\/Src activation. Oncotarget 8(20):32783","journal-title":"Oncotarget"},{"issue":"9","key":"6054_CR33","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1111\/cas.14135","volume":"110","author":"YH Huang","year":"2019","unstructured":"Huang YH, Chang CY, Kuo YZ, Fang WY, Kao HY, Tsai ST, Wu LW (2019) Cancer-associated fibroblast-derived interleukin-1\u03b2 activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer. Cancer Sci 110(9):2783","journal-title":"Cancer Sci"},{"issue":"3","key":"6054_CR34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.acthis.2016.12.005","volume":"119","author":"H Hussaini","year":"2017","unstructured":"Hussaini H, Parachuru V, Seymour G, Rich A (2017) Forkhead box-P3+ regulatory T cells and toll-like receptor 2 co-expression in oral squamous cell carcinoma. Acta Histochem 119(3):205\u2013210","journal-title":"Acta Histochem"},{"issue":"2","key":"6054_CR35","doi-asserted-by":"crossref","first-page":"151901","DOI":"10.1016\/j.imbio.2019.151901","volume":"225","author":"E Jablonska","year":"2020","unstructured":"Jablonska E, Garley M, Surazynski A, Grubczak K, Iwaniuk A, Borys J, Moniuszko M, Ratajczak-Wrona W (2020) Neutrophil extracellular traps (NETs) formation induced by TGF-\u03b2 in oral lichen planus\u2013possible implications for the development of oral cancer. Immunobiology 225(2):151901","journal-title":"Immunobiology"},{"key":"6054_CR36","doi-asserted-by":"crossref","unstructured":"Jayasingam SD, Citartan M, Thang TH, Zin AAM, Ang KC, Ch'ng ES (2019) Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice. Front Oncol 9","DOI":"10.3389\/fonc.2019.01512"},{"issue":"4","key":"6054_CR37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.imbio.2016.12.002","volume":"222","author":"C Jiang","year":"2017","unstructured":"Jiang C, Yuan F, Wang J, Wu L (2017) Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages. Immunobiology 222(4):651\u2013657","journal-title":"Immunobiology"},{"issue":"1","key":"6054_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6169-0","volume":"20","author":"X Jiang","year":"2020","unstructured":"Jiang X, Huang Z, Sun X, Zheng X, Liu J, Shen J, Jia B, Luo H, Mai Z, Chen G (2020) CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2\/STAT3 signaling pathway. BMC Cancer 20(1):1\u201313","journal-title":"BMC Cancer"},{"issue":"1","key":"6054_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-018-0930-x","volume":"18","author":"X Jiang","year":"2019","unstructured":"Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B, Wu X, Ma J, Zhou M, Li X (2019) Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape. Mol Cancer 18(1):1\u201317","journal-title":"Mol Cancer"},{"key":"6054_CR40","doi-asserted-by":"publisher","unstructured":"Jin RU, Mills JC (2020) Tumor organoids to study gastroesophageal cancer: a primer. J Mol Cell Biol. https:\/\/doi.org\/10.1093\/jmcb\/mjaa035","DOI":"10.1093\/jmcb\/mjaa035"},{"issue":"2","key":"6054_CR41","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3390\/cancers6020756","volume":"6","author":"SD Johnson","year":"2014","unstructured":"Johnson SD, De Costa A-MA, Young MRI (2014) Effect of the premalignant and tumor microenvironment on immune cell cytokine production in head and neck cancer. Cancers (Basel) 6(2):756\u2013770","journal-title":"Cancers (Basel)"},{"issue":"1","key":"6054_CR42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/jomfp.JOMFP_42_19","volume":"24","author":"I Joseph","year":"2020","unstructured":"Joseph I, Elizabeth J, Rao UK, Ranganathan K (2020) Study of hypoxia-inducible factor-2\u03b1 expression in the malignant transformation of Oral submucous fibrosis. J Oral Maxillofac Pathol 24(1):33","journal-title":"J Oral Maxillofac Pathol"},{"key":"6054_CR43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.oraloncology.2018.03.004","volume":"80","author":"JP Joseph","year":"2018","unstructured":"Joseph JP, Harishankar M, Pillai AA, Devi A (2018) Hypoxia induced EMT: a review on the mechanism of tumor progression and metastasis in OSCC. Oral Oncol 80:23\u201332","journal-title":"Oral Oncol"},{"issue":"7","key":"6054_CR44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/pharmaceutics11070302","volume":"11","author":"F Ketabat","year":"2019","unstructured":"Ketabat F, Pundir M, Mohabatpour F, Lobanova L, Koutsopoulos S, Hadjiiski L, Chen X, Papagerakis P, Papagerakis S (2019) Controlled drug delivery systems for oral cancer treatment\u2014current status and future perspectives. Pharmaceutics 11(7):302","journal-title":"Pharmaceutics"},{"issue":"8","key":"6054_CR45","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1369\/jhc.2008.951061","volume":"56","author":"Y Kikuchi","year":"2008","unstructured":"Kikuchi Y, Kashima TG, Nishiyama T, Shimazu K, Morishita Y, Shimazaki M, Kii I, Horie H, Nagai H, Kudo A (2008) Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon. J Histochem Cytochem 56(8):753\u2013764","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"6054_CR46","volume":"14","author":"DK Kim","year":"2019","unstructured":"Kim DK, Kim EK, Jung D-W, Kim J (2019) Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts. PLoS One 14(3):e0214553","journal-title":"PLoS One"},{"issue":"4","key":"6054_CR47","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3892\/ol.2015.2914","volume":"9","author":"JI Kim","year":"2015","unstructured":"Kim JI, Choi KU, Lee IS, Choi YJ, Kim WT, Shin DH, Kim K, Lee JH, Kim JY, Sol MY (2015) Expression of hypoxic markers and their prognostic significance in soft tissue sarcoma. Oncol Lett 9(4):1699\u20131706","journal-title":"Oncol Lett"},{"issue":"3","key":"6054_CR48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033009","volume":"10","author":"A Kong","year":"2020","unstructured":"Kong A, Good J, Kirkham A, Savage J, Mant R, Llewellyn L, Parish J, Spruce R, Forster M, Schipani S (2020) Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol. BMJ Open 10(3):e033009","journal-title":"BMJ Open"},{"issue":"10","key":"6054_CR49","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ijom.2019.04.004","volume":"48","author":"A Kouketsu","year":"2019","unstructured":"Kouketsu A, Sato I, Oikawa M, Shimizu Y, Saito H, Tashiro K, Yamashita Y, Takahashi T, Kumamoto H (2019) Regulatory T cells and M2-polarized tumour-associated macrophages are associated with the oncogenesis and progression of oral squamous cell carcinoma. Int J Oral Maxillofac Surg 48(10):1279\u20131288","journal-title":"Int J Oral Maxillofac Surg"},{"key":"6054_CR50","doi-asserted-by":"publisher","unstructured":"Kumar V, Patel S, Tcyganov E, Gabrilovich DI (2016) The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol 37(3):208\u2013220. https:\/\/doi.org\/10.1016\/j.it.2016.01.004","DOI":"10.1016\/j.it.2016.01.004"},{"key":"6054_CR51","doi-asserted-by":"crossref","unstructured":"Lakshminarayana S, Augustine D, Rao RS, Patil S, Awan KH, Venkatesiah SS, Haragannavar VC, Nambiar S, Prasad K (2018) Molecular pathways of oral cancer that predict prognosis and survival: a systematic review. J Carcinogenesis 17","DOI":"10.4103\/jcar.JCar_17_18"},{"issue":"3","key":"6054_CR52","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7785\/tcrt.2012.500312","volume":"12","author":"C Lan","year":"2013","unstructured":"Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T, Lu J, Liu J (2013) Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol Cancer Res Treat 12(3):259\u2013267","journal-title":"Technol Cancer Res Treat"},{"issue":"3","key":"6054_CR53","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1245\/s10434-013-3400-0","volume":"21","author":"C-H Lee","year":"2014","unstructured":"Lee C-H, Liu S-Y, Chou K-C, Yeh C-T, Shiah S-G, Huang R-Y, Cheng J-C, Yen C-Y, Shieh Y-S (2014) Tumor-associated macrophages promote oral cancer progression through activation of the Axl signaling pathway. Ann Surg Oncol 21(3):1031\u20131037","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"6054_CR54","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/jclinpath-2015-203089","volume":"69","author":"HJ Lee","year":"2016","unstructured":"Lee HJ, Park IA, Song IH, Shin SJ, Kim JY, Yu JH, Gong G (2016) Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer. J Clin Pathol 69(5):422\u2013430. https:\/\/doi.org\/10.1136\/jclinpath-2015-203089","journal-title":"J Clin Pathol"},{"issue":"2","key":"6054_CR55","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4049\/jimmunol.1601815","volume":"199","author":"J-J Lee","year":"2017","unstructured":"Lee J-J, Kao K-C, Chiu Y-L, Jung C-J, Liu C-J, Cheng S-J, Chang Y-L, Ko J-Y, Chia J-S (2017) Enrichment of human CCR6+ regulatory T cells with superior suppressive activity in oral cancer. J Immunol 199(2):467\u2013476","journal-title":"J Immunol"},{"issue":"11","key":"6054_CR56","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.18632\/oncotarget.23934","volume":"9","author":"M-H Lee","year":"2018","unstructured":"Lee M-H, Chang JT-C, Liao C-T, Chen Y-S, Kuo M-L, Shen C-R (2018) Interleukin 17 and peripheral IL-17-expressing T cells are negatively correlated with the overall survival of head and neck cancer patients. Oncotarget 9(11):9825","journal-title":"Oncotarget"},{"issue":"7","key":"6054_CR57","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00432-019-02922-2","volume":"145","author":"B Li","year":"2019","unstructured":"Li B, Liu Y, Hu T, Zhang Y, Zhang C, Li T, Wang C, Dong Z, Novakovic VA, Hu T (2019) Neutrophil extracellular traps enhance procoagulant activity in patients with oral squamous cell carcinoma. J Cancer Res Clin Oncol 145(7):1695\u20131707","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"6054_CR58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41368-020-00092-3","volume":"12","author":"Q Li","year":"2020","unstructured":"Li Q, Liu X, Wang D, Wang Y, Lu H, Wen S, Fang J, Cheng B, Wang Z (2020) Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma. Int J Oral Sci 12(1):24. https:\/\/doi.org\/10.1038\/s41368-020-00092-3","journal-title":"Int J Oral Sci"},{"key":"6054_CR59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ebiom.2018.09.006","volume":"36","author":"Y-Y Li","year":"2018","unstructured":"Li Y-Y, Tao Y-W, Gao S, Li P, Zheng J-M, Zhang S-E, Liang J, Zhang Y (2018a) Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. EBioMedicine 36:209\u2013220","journal-title":"EBioMedicine"},{"issue":"1","key":"6054_CR60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yexcr.2018.04.029","volume":"369","author":"Y-U Li","year":"2018","unstructured":"Li Y-U, Zhou C-X, Gao Y (2018b) Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-\u03b21 mediated by podoplanin. Exp Cell Res 369(1):43\u201353","journal-title":"Exp Cell Res"},{"issue":"1","key":"6054_CR61","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1186\/s12885-019-6229-5","volume":"19","author":"Y-W Lin","year":"2019","unstructured":"Lin Y-W, Huang S-T, Wu J-C, Chu T-H, Huang S-C, Lee C-C, Tai M-H (2019) Novel HDGF\/HIF-1\u03b1\/VEGF axis in oral cancer impacts disease prognosis. BMC Cancer 19(1):1083","journal-title":"BMC Cancer"},{"key":"6054_CR62","doi-asserted-by":"crossref","first-page":"108608","DOI":"10.1016\/j.biopha.2019.108608","volume":"112","author":"Y Lu","year":"2019","unstructured":"Lu Y, Li Y, Wang Z, Xie S, Wang Q, Lei X, Ruan Y, Li J (2019) Downregulation of RGMA by HIF-1A\/miR-210-3p axis promotes cell proliferation in oral squamous cell carcinoma. Biomed Pharmacother 112:108608","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"6054_CR63","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hed.24667","volume":"39","author":"I Luksic","year":"2017","unstructured":"Luksic I, Suton P (2017) Predictive markers for delayed lymph node metastases and survival in early-stage oral squamous cell carcinoma. Head Neck 39(4):694\u2013701","journal-title":"Head Neck"},{"issue":"5","key":"6054_CR64","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.4049\/jimmunol.1500703","volume":"195","author":"GM Mason","year":"2015","unstructured":"Mason GM, Lowe K, Melchiotti R, Ellis R, de Rinaldis E, Peakman M, Heck S, Lombardi G, Tree TI (2015) Phenotypic complexity of the human regulatory T cell compartment revealed by mass cytometry. J Immunol 195(5):2030\u20132037","journal-title":"J Immunol"},{"key":"6054_CR65","doi-asserted-by":"crossref","unstructured":"Mello FW, Melo G, Pasetto JJ, Silva CAB, Warnakulasuriya S, Rivero ER (2019) The synergistic effect of tobacco and alcohol consumption on oral squamous cell carcinoma: a systematic review and meta-analysis. Clin Oral Investig:1\u201311","DOI":"10.1007\/s00784-019-02958-1"},{"key":"6054_CR66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","volume":"3","author":"B Muz","year":"2015","unstructured":"Muz B, de la Puente P, Azab F, Azab AK (2015) The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia 3:83","journal-title":"Hypoxia"},{"issue":"7","key":"6054_CR67","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1007\/s13277-015-3189-5","volume":"36","author":"YH Ni","year":"2015","unstructured":"Ni YH, Ding L, Huang XF, Dong YC, Hu QG, Hou YY (2015) Microlocalization of CD68+ tumor-associated macrophages in tumor stroma correlated with poor clinical outcomes in oral squamous cell carcinoma patients. Tumour Biol 36(7):5291\u20135298. https:\/\/doi.org\/10.1007\/s13277-015-3189-5","journal-title":"Tumour Biol"},{"issue":"1","key":"6054_CR68","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12943-019-0983-5","volume":"18","author":"B Peltanova","year":"2019","unstructured":"Peltanova B, Raudenska M, Masarik M (2019) Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Mol Cancer 18(1):63","journal-title":"Mol Cancer"},{"issue":"1","key":"6054_CR69","first-page":"1","volume":"12","author":"MNMR Petruzzi","year":"2017","unstructured":"Petruzzi MNMR, Cherubini K, Salum FG, De Figueiredo MAZ (2017) Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge. Diagn Pathol 12(1):1\u20137","journal-title":"Diagn Pathol"},{"issue":"3","key":"6054_CR70","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.critrevonc.2011.06.004","volume":"82","author":"H Piccard","year":"2012","unstructured":"Piccard H, Muschel R, Opdenakker G (2012) On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol\/Hematol 82(3):296\u2013309","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"2","key":"6054_CR71","first-page":"605","volume":"34","author":"DEL PO","year":"2014","unstructured":"PO DEL, Jorge CC, Oliveira DT, Pereira MC (2014) Hypoxic condition and prognosis in oral squamous cell carcinoma. Anticancer Res 34(2):605\u2013612","journal-title":"Anticancer Res"},{"issue":"4","key":"6054_CR72","first-page":"457","volume":"49","author":"C Qian","year":"2019","unstructured":"Qian C, Dai Y, Xu X, Jiang Y, Science L (2019) HIF-1\u03b1 regulates proliferation and invasion of Oral Cancer cells through Kv3. 4 channel. Ann Clin Lab Sci 49(4):457\u2013467","journal-title":"Ann Clin Lab Sci"},{"key":"6054_CR73","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3389\/fonc.2019.01370","volume":"9","author":"S Quintero-Fabi\u00e1n","year":"2019","unstructured":"Quintero-Fabi\u00e1n S, Arreola R, Becerril-Villanueva E, Torres-Romero JC, Arana-Arg\u00e1ez V, Lara-Riegos J, Ram\u00edrez-Camacho MA, Alvarez-S\u00e1nchez ME (2019) Role of matrix metalloproteinases in angiogenesis and Cancer. Front Oncol 9:1370. https:\/\/doi.org\/10.3389\/fonc.2019.01370","journal-title":"Front Oncol"},{"issue":"12","key":"6054_CR74","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/ijc.28622","volume":"134","author":"PL Raber","year":"2014","unstructured":"Raber PL, Thevenot P, Sierra R, Wyczechowska D, Halle D, Ramirez ME, Ochoa AC, Fletcher M, Velasco C, Wilk A (2014) Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways. Int J Cancer 134(12):2853\u20132864","journal-title":"Int J Cancer"},{"issue":"1","key":"6054_CR75","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2407-11-167","volume":"11","author":"SE Rademakers","year":"2011","unstructured":"Rademakers SE, Lok J, van der Kogel AJ, Bussink J, Kaanders J (2011) Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1\u03b1, CAIX, LDH-5, GLUT-1, MCT1 and MCT4. BMC Cancer 11(1):167","journal-title":"BMC Cancer"},{"issue":"5","key":"6054_CR76","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1002\/jcb.26905","volume":"120","author":"S Ricci","year":"2019","unstructured":"Ricci S, Pinto F, Auletta A, Giordano A, Giovane A, Settembre G, Boccellino M, Boffo S, Di Carlo A, Di Domenico M (2019) The enigmatic role of matrix metalloproteinases in epithelial-to-mesenchymal transition of oral squamous cell carcinoma: implications and nutraceutical aspects. J Cell Biochem 120(5):6813\u20136819","journal-title":"J Cell Biochem"},{"key":"6054_CR77","doi-asserted-by":"publisher","unstructured":"Roma-Rodrigues C, Mendes R, Baptista PV, Fernandes AR (2019) Targeting tumor microenvironment for Cancer therapy. Int J Mol Sci 20(4). https:\/\/doi.org\/10.3390\/ijms20040840","DOI":"10.3390\/ijms20040840"},{"issue":"7 Suppl","key":"6054_CR78","doi-asserted-by":"publisher","first-page":"29s","DOI":"10.1177\/0022034514527969","volume":"93","author":"N Sathish","year":"2014","unstructured":"Sathish N, Wang X, Yuan Y (2014) Human papillomavirus (HPV)-associated Oral cancers and treatment strategies. J Dent Res 93(7 Suppl):29s\u201336s. https:\/\/doi.org\/10.1177\/0022034514527969","journal-title":"J Dent Res"},{"issue":"3","key":"6054_CR79","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1368-8375(00)00007-5","volume":"36","author":"C Scully","year":"2000","unstructured":"Scully C, Field J, Tanzawa H (2000) Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 36(3):256\u2013263","journal-title":"Oral Oncol"},{"issue":"7","key":"6054_CR80","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.it.2019.04.012","volume":"40","author":"C Silvestre-Roig","year":"2019","unstructured":"Silvestre-Roig C, Fridlender ZG, Glogauer M, Scapini P (2019) Neutrophil diversity in health and disease. Trends Immunol 40(7):565\u2013583. https:\/\/doi.org\/10.1016\/j.it.2019.04.012","journal-title":"Trends Immunol"},{"issue":"1","key":"6054_CR81","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coms.2018.09.002","volume":"31","author":"F Sim","year":"2019","unstructured":"Sim F, Leidner R, Bell RB (2019) Immunotherapy for head and neck cancer. Oral Maxillofac Surg Clin North Am 31(1):85\u2013100","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"6054_CR82","first-page":"12","volume":"61","author":"N Sinevici","year":"2016","unstructured":"Sinevici N, O\u2019sullivan J (2016) Oral cancer: deregulated molecular events and their use as biomarkers. Oraloncology 61:12\u201318","journal-title":"Oraloncology"},{"key":"6054_CR83","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s12885-016-2419-6","volume":"16","author":"JJ Song","year":"2016","unstructured":"Song JJ, Zhao SJ, Fang J, Ma D, Liu XQ, Chen XB, Wang Y, Cheng B, Wang Z (2016) Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma. BMC Cancer 16:530. https:\/\/doi.org\/10.1186\/s12885-016-2419-6","journal-title":"BMC Cancer"},{"key":"6054_CR84","doi-asserted-by":"crossref","unstructured":"Spenl\u00e9 C, Loustau T, Murdamoothoo D, Erne W, Beghelli-de la Forest Divonne S, Veber R, Petti L, Bourdely P, M\u00f6rgelin M, Brauchle E (2020) Tenascin-C orchestrates an immune suppressive tumor microenvironment in oral squamous cell carcinoma. Cancer Immunol Res","DOI":"10.1158\/2326-6066.CIR-20-0074"},{"issue":"7","key":"6054_CR85","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3390\/cancers12071764","volume":"12","author":"FJ Su\u00e1rez-S\u00e1nchez","year":"2020","unstructured":"Su\u00e1rez-S\u00e1nchez FJ, Lequerica-Fern\u00e1ndez P, Su\u00e1rez-Canto J, Rodrigo JP, Rodriguez-Santamarta T, Dom\u00ednguez-Iglesias F, Garc\u00eda-Pedrero JM, de Vicente JC (2020) Macrophages in Oral carcinomas: relationship with Cancer stem cell markers and PD-L1 expression. Cancers (Basel) 12(7):1764","journal-title":"Cancers (Basel)"},{"issue":"5","key":"6054_CR86","first-page":"314","volume":"18","author":"N Taghavi","year":"2015","unstructured":"Taghavi N (2015) Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts. Arch Iran Med 18(5):314\u2013319","journal-title":"Arch Iran Med"},{"issue":"2","key":"6054_CR87","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.acthis.2012.05.001","volume":"115","author":"R Tamamura","year":"2013","unstructured":"Tamamura R, Nagatsuka H, Siar CH, Katase N, Naito I, Sado Y, Nagai N (2013) Comparative analysis of basal lamina type IV collagen \u03b1 chains, matrix metalloproteinases-2 and-9 expressions in oral dysplasia and invasive carcinoma. Acta Histochem 115(2):113\u2013119","journal-title":"Acta Histochem"},{"issue":"6","key":"6054_CR88","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.joms.2020.01.001","volume":"78","author":"S Tazeen","year":"2020","unstructured":"Tazeen S, Prasad K, Harish K, Sagar P, Kapali AS, Chandramouli S (2020) Assessment of pretreatment neutrophil\/lymphocyte ratio and platelet\/lymphocyte ratio in prognosis of Oral squamous cell carcinoma. J Oral Maxillofacial Surg Off J Am Assoc Oral Maxillofacial Surgeons 78(6):949\u2013960. https:\/\/doi.org\/10.1016\/j.joms.2020.01.001","journal-title":"J Oral Maxillofacial Surg Off J Am Assoc Oral Maxillofacial Surgeons"},{"issue":"10","key":"6054_CR89","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.3390\/ijms19103028","volume":"19","author":"C Walker","year":"2018","unstructured":"Walker C, Mojares E, del R\u00edo Hern\u00e1ndez A (2018) Role of extracellular matrix in development and cancer progression. Int J Mol Sci 19(10):3028","journal-title":"Int J Mol Sci"},{"key":"6054_CR90","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3389\/fimmu.2018.00830","volume":"9","author":"C Wang","year":"2018","unstructured":"Wang C, Dickie J, Sutavani RV, Pointer C, Thomas GJ, Savelyeva N (2018a) Targeting head and neck cancer by vaccination. Front Immunol 9:830","journal-title":"Front Immunol"},{"key":"6054_CR91","doi-asserted-by":"publisher","unstructured":"Wang J, Sanmamed MF, Datar I, Su TT, Ji L, Sun J, Chen L, Chen Y, Zhu G, Yin W, Zheng L, Zhou T, Badri T, Yao S, Zhu S, Boto A, Sznol M, Melero I, Vignali DAA, Schalper K (2019a) Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3. Cell, 176(1\u20132):334\u2013347. https:\/\/doi.org\/10.1016\/j.cell.2018.11.010","DOI":"10.1016\/j.cell.2018.11.010"},{"key":"6054_CR92","doi-asserted-by":"publisher","unstructured":"Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, Gong Z, Zhang S, Zhou J, Cao K, Li X, Xiong W, Li G, Zeng Z, Guo C (2017). Role of tumor microenvironment in tumorigenesis. J Cancer 8(5):761\u2013773. https:\/\/doi.org\/10.7150\/jca.17648","DOI":"10.7150\/jca.17648"},{"issue":"4","key":"6054_CR93","first-page":"5694","volume":"15","author":"X Wang","year":"2018","unstructured":"Wang X, Zhang W, Sun X, Lin Y, Chen W (2018b) Cancerassociated fibroblasts induce epithelialmesenchymal transition through secreted cytokines in endometrial cancer cells. Oncol Lett 15(4):5694\u20135702","journal-title":"Oncol Lett"},{"issue":"1","key":"6054_CR94","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1038\/s41467-019-13471-0","volume":"10","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wu VH, Allevato MM, Gilardi M, He Y, Luis Callejas-Valera J, Vitale-Cross L, Martin D, Amornphimoltham P, McDermott J, Yung BS, Goto Y, Molinolo AA, Sharabi AB, Cohen EEW, Chen Q, Lyons JG, Alexandrov LB, Gutkind JS (2019b) Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4. Nat Commun 10(1):5546. https:\/\/doi.org\/10.1038\/s41467-019-13471-0","journal-title":"Nat Commun"},{"issue":"6","key":"6054_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099568","volume":"9","author":"K Watari","year":"2014","unstructured":"Watari K, Shibata T, Kawahara A, Sata K, Nabeshima H, Shinoda A, Abe H, Azuma K, Murakami Y, Izumi H, Takahashi T, Kage M, Kuwano M, Ono M (2014) Tumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophages. PLoS One 9(6):e99568. https:\/\/doi.org\/10.1371\/journal.pone.0099568","journal-title":"PLoS One"},{"issue":"7","key":"6054_CR96","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jcms.2014.01.035","volume":"42","author":"M Weber","year":"2014","unstructured":"Weber M, B\u00fcttner-Herold M, Hyckel P, Moebius P, Distel L, Ries J, Amann K, Neukam FW, Wehrhan F (2014) Small oral squamous cell carcinomas with nodal lymphogenic metastasis show increased infiltration of M2 polarized macrophages\u2013an immunohistochemical analysis. J Cranio-Maxillofac Surg 42(7):1087\u20131094","journal-title":"J Cranio-Maxillofac Surg"},{"issue":"13","key":"6054_CR97","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1177\/0022034519882618","volume":"98","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, Li H, Mao L, Yang QC, Fu LQ, Wu CC, Liu B, Sun Z (2019) CD103(+) T and dendritic cells indicate a favorable prognosis in Oral Cancer. J Dent Res 98(13):1480\u20131487. https:\/\/doi.org\/10.1177\/0022034519882618","journal-title":"J Dent Res"},{"issue":"10","key":"6054_CR98","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.joms.2017.03.009","volume":"75","author":"Y Yamagata","year":"2017","unstructured":"Yamagata Y, Tomioka H, Sakamoto K, Sato K, Harada H, Ikeda T, Kayamori K (2017) CD163-positive macrophages within the tumor stroma are associated with lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma. J Oral Maxillofacial Surg Off J Am Assoc Oral Maxillofacial Surg 75(10):2144\u20132153","journal-title":"J Oral Maxillofacial Surg Off J Am Assoc Oral Maxillofacial Surg"},{"issue":"1\u20132","key":"6054_CR99","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/19336918.2015.1008332","volume":"9","author":"T Yoshida","year":"2015","unstructured":"Yoshida T, Akatsuka T, Imanaka-Yoshida K, migration (2015) Tenascin-C and integrins in cancer. Cell Adhes Migr 9(1\u20132):96\u2013104","journal-title":"Cell Adhes Migr"},{"issue":"2","key":"6054_CR100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1158\/1541-7786.MCR-10-0386","volume":"9","author":"T Yu","year":"2011","unstructured":"Yu T, Wu Y, Helman JI, Wen Y, Wang C, Li L (2011) CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway. Mol Cancer Res 9(2):161\u2013172","journal-title":"Mol Cancer Res"},{"key":"6054_CR101","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejca.2018.11.015","volume":"107","author":"DP Zandberg","year":"2019","unstructured":"Zandberg DP, Algazi AP, Jimeno A, Good JS, Fayette J, Bouganim N, Ready NE, Clement PM, Even C, Jang RW (2019) Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: results from a single-arm, phase II study in patients with\u2265 25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy. Eur J Cancer 107:142\u2013152","journal-title":"Eur J Cancer"},{"issue":"5","key":"6054_CR102","first-page":"4771","volume":"18","author":"C Zeng","year":"2019","unstructured":"Zeng C, Kuang H, Fan W, Chen X, Yu T, Tang Q, Zhou Z, Liang F (2019) Downregulation of FOXP3 in neutrophils by IL8 promotes the progression of oral squamous cell carcinoma. Oncol Lett 18(5):4771\u20134777","journal-title":"Oncol Lett"},{"issue":"12","key":"6054_CR103","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00262-015-1765-6","volume":"64","author":"H Zhang","year":"2015","unstructured":"Zhang H, Li Z-L, Ye S-B, Ouyang L-Y, Chen Y-S, He J, Huang H-Q, Zeng Y-X, Zhang X-S, Li J (2015) Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK\/T cell lymphoma: a novel prognostic indicator. Cancer Immunol Immunoth 64(12):1587\u20131599","journal-title":"Cancer Immunol Immunoth"},{"issue":"4","key":"6054_CR104","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.178.4.2018","volume":"178","author":"SG Zheng","year":"2007","unstructured":"Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA (2007) IL-2 is essential for TGF-\u03b2 to convert naive CD4+ CD25\u2212 cells to CD25+ Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 178(4):2018\u20132027","journal-title":"J Immunol"},{"key":"6054_CR105","unstructured":"WHO (2019) Oral cancer. https:\/\/www.who.int\/cancer\/prevention\/diagnosis-screening\/oral-cancer\/en\/. Accessed in August, 2020"},{"key":"6054_CR106","unstructured":"WHO (2020) International classification of diseases for oncology (ICD-O) .https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/96612\/9789241548496_eng.pdf?sequence=1. Accessed in August, 2020"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-06054-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-020-06054-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-06054-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T16:11:42Z","timestamp":1614701502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-020-06054-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["6054"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-06054-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"17 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the authors agree and give consent for the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}